Zhang S, Casanova J
Nature. 2024; 635(8039):563-573.
PMID: 39567785
PMC: 11822754.
DOI: 10.1038/s41586-024-08119-z.
Ladak R, Choi J, Luo J, Chen O, Mahmood N, He A
Proc Natl Acad Sci U S A. 2024; 121(48):e2413018121.
PMID: 39560640
PMC: 11621783.
DOI: 10.1073/pnas.2413018121.
Antony F, Kinha D, Nowinska A, Rouse B, Suryawanshi A
Clin Microbiol Rev. 2024; 37(3):e0000624.
PMID: 39078136
PMC: 11391706.
DOI: 10.1128/cmr.00006-24.
Hedberg J, Studebaker A, Smith L, Chen C, Westfall J, Cam M
Mol Ther Oncolytics. 2023; 30:39-55.
PMID: 37583388
PMC: 10424001.
DOI: 10.1016/j.omto.2023.07.006.
Chau V, Kolb A, Miller D, Yannuzzi N, Brandt C
Invest Ophthalmol Vis Sci. 2023; 64(10):16.
PMID: 37450309
PMC: 10353747.
DOI: 10.1167/iovs.64.10.16.
Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers.
Vannini A, Parenti F, Forghieri C, Barboni C, Zaghini A, Campadelli-Fiume G
Front Mol Biosci. 2023; 10:1149973.
PMID: 37251078
PMC: 10213976.
DOI: 10.3389/fmolb.2023.1149973.
Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12.
Fukuhara H, Sato Y, Hou J, Iwai M, Todo T
Commun Med (Lond). 2023; 3(1):40.
PMID: 36966232
PMC: 10039936.
DOI: 10.1038/s43856-023-00270-4.
Herpes Simplex Virus Type 1 Preferentially Enhances Neuro-Inflammation and Senescence in Brainstem of Female Mice.
Sivasubramanian M, Monteiro R, Harrison K, Plakkot B, Subramanian M, Jones C
J Virol. 2022; 96(17):e0108122.
PMID: 35975996
PMC: 9472638.
DOI: 10.1128/jvi.01081-22.
Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade.
Ju F, Luo Y, Lin C, Jia X, Xu Z, Tian R
J Immunother Cancer. 2022; 10(6).
PMID: 35688558
PMC: 9189843.
DOI: 10.1136/jitc-2022-004762.
HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens.
Koelle D, Dong L, Jing L, Laing K, Zhu J, Jin L
Front Immunol. 2022; 13:867962.
PMID: 35432373
PMC: 9009524.
DOI: 10.3389/fimmu.2022.867962.
Clinical, neuropathological, and immunological short- and long-term feature of a mouse model mimicking human herpes virus encephalitis.
Sehl-Ewert J, Schwaiger T, Schafer A, Holper J, Klupp B, Teifke J
Brain Pathol. 2021; 32(3):e13031.
PMID: 34709694
PMC: 9048517.
DOI: 10.1111/bpa.13031.
Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV.
Gianni T, Leoni V, Sanapo M, Parenti F, Bressanin D, Barboni C
Viruses. 2021; 13(9).
PMID: 34578328
PMC: 8473155.
DOI: 10.3390/v13091747.
Vaginal HSV-2 Infection and Tissue Analysis.
Iversen M, Paludan S, Holm C
Bio Protoc. 2021; 7(13):e2383.
PMID: 34541121
PMC: 8413646.
DOI: 10.21769/BioProtoc.2383.
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment.
De Lucia M, Cotugno G, Bignone V, Garzia I, Nocchi L, Langone F
Mol Ther Oncolytics. 2020; 19:253-264.
PMID: 33209980
PMC: 7658578.
DOI: 10.1016/j.omto.2020.10.006.
Host Intrinsic and Innate Intracellular Immunity During Herpes Simplex Virus Type 1 (HSV-1) Infection.
Alandijany T
Front Microbiol. 2019; 10:2611.
PMID: 31781083
PMC: 6856869.
DOI: 10.3389/fmicb.2019.02611.
The ESCRT-Related ATPase Vps4 Is Modulated by Interferon during Herpes Simplex Virus 1 Infection.
Cabrera J, Manivanh R, North B, Leib D
mBio. 2019; 10(2).
PMID: 30837340
PMC: 6401484.
DOI: 10.1128/mBio.02567-18.
The recruitment of peripheral blood leukocytes to the brain is delayed in susceptible BALB/c compared to resistant C57BL/6 mice during herpes simplex virus encephalitis.
Canivet C, Uyar O, Rheaume C, Piret J, Boivin G
J Neurovirol. 2019; 25(3):372-383.
PMID: 30758810
DOI: 10.1007/s13365-019-00730-5.
An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma.
Xu B, Ma R, Russell L, Yoo J, Han J, Cui H
Nat Biotechnol. 2018; .
PMID: 30475349
PMC: 6535376.
DOI: 10.1038/nbt.4302.
Insights into the pathogenesis of herpes simplex encephalitis from mouse models.
Mancini M, Vidal S
Mamm Genome. 2018; 29(7-8):425-445.
PMID: 30167845
PMC: 6132704.
DOI: 10.1007/s00335-018-9772-5.
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors.
Leoni V, Vannini A, Gatta V, Rambaldi J, Sanapo M, Barboni C
PLoS Pathog. 2018; 14(8):e1007209.
PMID: 30080893
PMC: 6095629.
DOI: 10.1371/journal.ppat.1007209.
